{"lastClose": 1.2000000476837158, "len": 476, "date": "2023-02-07", "alpha_1": -0.917918036687783, "beta_1": 0.20200393030843133, "drawup_1": 0.7325581218050006, "natr_1": 30.37948901477851, "sup_1": -0.03583338383171086, "res_1": 0.28583323482010503, "bullPattern_1": [], "bearPattern_1": [], "rsi_1": 61.91467208735993, "adx_1": 24.049051244717102, "drawdown_1": -0.9065934078890032, "stratHoldSharpe_1": -1.820359788847555, "stratHoldAlpha_1": 249.73622371174045, "stratHoldDrawdown_1": -0.8177312854970592, "alpha_3mo": -0.7202105512487293, "beta_3mo": -0.47705733900908304, "drawup_3mo": 0.4117647223819081, "natr_3mo": 30.37948901477851, "sup_3mo": -0.05888898933374924, "res_3mo": 0.007222095838304526, "bullPattern_3mo": ["HIGHWAVE", "SPINNINGTOP"], "bearPattern_3mo": [], "rsi_3mo": 73.12500271635706, "adx_3mo": 53.639471266908124, "drawdown_3mo": -0.4295301889923263, "stratHoldSharpe_3mo": 0.9712439544605221, "stratHoldAlpha_3mo": 251.67157675987244, "stratHoldDrawdown_3mo": -0.39779004255845685, "Industry": "Biotechnology: In Vitro & In Vivo Diagnostic Substances", "Market Cap": 308293569, "Country": "Cayman Islands", "Name": "LumiraDx Limited", "Sector": "Health Care", "alpha%_1": 0.004074730950849551, "beta%_1": 0.06384111374321846, "drawup%_1": 0.6889431697591206, "natr%_1": 1.0, "drawdown%_1": 0.0046208669007438636, "stratHoldSharpe%_1": 0.001989198533478352, "stratHoldAlpha%_1": 9.59053879795503e-08, "stratHoldDrawdown%_1": 0.005710148670505577, "alpha%_3mo": 0.07282243479297518, "beta%_3mo": 0.009331407209959435, "drawup%_3mo": 0.8122422557368825, "natr%_3mo": 1.0, "drawdown%_3mo": 0.0014056077143312876, "stratHoldSharpe%_3mo": 0.447639071760276, "stratHoldAlpha%_3mo": 0.7206853408684679, "stratHoldDrawdown%_3mo": 0.001047351052105531}